Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP434035.RAtygGSSGRd_6S5ly_bTF8_TufBz6PVWU_kxpZ7nWEuyI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP434035.RAtygGSSGRd_6S5ly_bTF8_TufBz6PVWU_kxpZ7nWEuyI130_assertion type Assertion NP434035.RAtygGSSGRd_6S5ly_bTF8_TufBz6PVWU_kxpZ7nWEuyI130_head.
- NP434035.RAtygGSSGRd_6S5ly_bTF8_TufBz6PVWU_kxpZ7nWEuyI130_assertion description "[The TLR9-mediated activation of the vertebrate immune system suggests using such TLR9 agonists as effective vaccine adjuvants for infectious disease, and for the treatment of cancer and asthma/allergy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP434035.RAtygGSSGRd_6S5ly_bTF8_TufBz6PVWU_kxpZ7nWEuyI130_provenance.
- NP434035.RAtygGSSGRd_6S5ly_bTF8_TufBz6PVWU_kxpZ7nWEuyI130_assertion evidence source_evidence_literature NP434035.RAtygGSSGRd_6S5ly_bTF8_TufBz6PVWU_kxpZ7nWEuyI130_provenance.
- NP434035.RAtygGSSGRd_6S5ly_bTF8_TufBz6PVWU_kxpZ7nWEuyI130_assertion SIO_000772 18020622 NP434035.RAtygGSSGRd_6S5ly_bTF8_TufBz6PVWU_kxpZ7nWEuyI130_provenance.
- NP434035.RAtygGSSGRd_6S5ly_bTF8_TufBz6PVWU_kxpZ7nWEuyI130_assertion wasDerivedFrom befree-20140225 NP434035.RAtygGSSGRd_6S5ly_bTF8_TufBz6PVWU_kxpZ7nWEuyI130_provenance.
- NP434035.RAtygGSSGRd_6S5ly_bTF8_TufBz6PVWU_kxpZ7nWEuyI130_assertion wasGeneratedBy ECO_0000203 NP434035.RAtygGSSGRd_6S5ly_bTF8_TufBz6PVWU_kxpZ7nWEuyI130_provenance.